The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Grant Julie Papanek since 2016.
This trader's CIK number is 1673237.
At the time of last reporting, Grant Julie Papanek was the Director of Day One Biopharmaceuticals, Inc.. (stock ticker symbol DAWN).
Also see all insider trading activities at Day One Biopharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | PTGX | 583,333 | $6,999,996 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | DAWN | 0 | $0 | 75,000 | $1,522,373 | 0 | $0 |
| 2022 | DAWN | 0 | $0 | 1,249,344 | $25,606,775 | 0 | $0 |
| 2021 | DAWN | 13,000 | $208,000 | 0 | $0 | 0 | $0 |
1. Protagonist Therapeutics, Inc (PTGX)
2. Day One Biopharmaceuticals, Inc. (DAWN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-08-16 | PTGX | Buy | 583,333 | 12.00 | 6,999,996 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-01 | DAWN | Sale | 25,000 | 18.61 | 465,299 |
| 2023-02-01 | DAWN | Sale | 25,000 | 21.45 | 536,250 |
| 2023-01-03 | DAWN | Sale | 25,000 | 20.83 | 520,824 |
| 2022-12-08 | DAWN | Sale | 4,358 | 22.08 | 96,211 |
| 2022-12-01 | DAWN | Sale | 5,000 | 22.03 | 110,145 |
| 2022-12-02 | DAWN | Sale | 5,000 | 21.55 | 107,725 |
| 2022-10-04 | DAWN | Sale | 5,000 | 20.00 | 100,000 |
| 2022-10-03 | DAWN | Sale | 5,000 | 20.06 | 100,315 |
| 2022-09-21 | DAWN | Sale | 613,603 | 18.91 | 11,606,300 |
| 2022-09-19 | DAWN | Sale | 76,725 | 20.57 | 1,578,233 |
| 2022-09-20 | DAWN | Sale | 148,670 | 19.80 | 2,943,666 |
| 2022-09-16 | DAWN | Sale | 115,307 | 21.79 | 2,511,962 |
| 2022-09-13 | DAWN | Sale | 87,647 | 24.70 | 2,164,880 |
| 2022-09-14 | DAWN | Sale | 106,111 | 23.98 | 2,545,072 |
| 2022-09-15 | DAWN | Sale | 51,281 | 23.26 | 1,192,796 |
| 2022-09-02 | DAWN | Sale | 5,000 | 23.82 | 119,110 |
| 2022-09-01 | DAWN | Sale | 5,000 | 23.50 | 117,515 |
| 2022-08-04 | DAWN | Sale | 5,000 | 20.00 | 100,005 |
| 2022-08-05 | DAWN | Sale | 5,000 | 20.00 | 100,000 |
| 2022-07-18 | DAWN | Sale | 2,600 | 20.00 | 52,000 |
| 2022-07-08 | DAWN | Sale | 1,242 | 20.00 | 24,840 |
| 2022-07-01 | DAWN | Sale | 1,000 | 20.00 | 20,000 |
| 2022-07-05 | DAWN | Sale | 800 | 20.00 | 16,000 |
| 2021-06-01 | DAWN | Buy | 13,000 | 16.00 | 208,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grant Julie Papanek (Director of Day One Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.